San Clemente, CA – May 29, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug…
Read More
Recent Posts
- Reflow Medical Marks 15 Years of Medical Ingenuity in Cardiovascular Care
- Reflow Medical Reports Six-Month Results from DEEPER CORONARY Study of Spur® Elute Stent
- Checking the Pulse: News Updates for Q1 2026
- Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
- Reflow Medical Announces 12-Month Results from DEEPER REVEAL Trial: Sustained Outcomes with the Spur® Stent System in CLTI
Archives
- June 2026
- May 2026
- April 2026
- February 2026
- November 2025
- September 2025
- May 2025
- March 2025
- February 2025
- November 2024
- October 2024
- July 2024
- May 2024
- February 2024
- January 2024
- November 2023
- August 2023
- June 2023
- May 2023
- April 2023
- November 2022
- June 2022
- May 2022
- January 2021
- October 2020
- June 2020
- April 2020
- March 2020
- January 2020
- July 2019
- April 2019
- February 2019
- November 2018
- August 2018
- March 2018
- September 2017
- January 2016
- September 2015
- December 2014
- October 2014
- September 2014
- April 2014
Recent Comments